Mobile
  • Search
  • Advanced search
  • Multi-criteria search
  • Who are we ?
  • Log in
  • Sign up
  • Français
  • English

Kusajili – Clinical trials directory

Your research

Clear all filters

Filtres
organs
Specialty
Type
Promoter
  • nct (1)
Country
  • Australia (1)
  • Austria (1)
  • Belgium (1)
  • Bulgaria (1)
  • Canada (1)
  • Czech Republic (1)
  • Finland (1)
  • France (1)
  • Germany (1)
  • Hungary (1)
  • Israel (1)
  • Italy (1)
  • Netherlands (1)
  • Poland (1)
  • Romania (1)
  • Russian Federation (1)
  • Serbia (1)
  • Spain (1)
  • Sweden (1)
  • Switzerland (1)
  • Ukraine (1)
  • United Kingdom (1)
  • United States (1)
Source
  • nct (1)
Phase
  • complete (1)

Country: Belgium,Netherlands,Sweden,Bulgaria,Romania,Israel
nct Update Il y a 5 ans

Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis This study will assess the efficacy, safety, and tolerability of ACT-128800 in patients with relapsing-remitting multiple sclerosis.

  • Country Australia, Austria, Belgium, Bulgaria, Canada, Czech Republic, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Romania, Russian Federation, Serbia, Spain, Sweden, Switzerland, Ukraine, United Kingdom, United States,
  • organs None
  • Specialty None
Closed trial
More information

  • 1

Who are we ?

Kusajili was created to respond to a request from physicians to simplify access to patient registries and inclusion. Kusajili is regularly updated according to new French and international trials. [email protected]

Kusajili and MyHomeDoctor

MyHomeDoctor software unique to the world, created with surgeons, for follow-up and analysis of patient follow-up. Kusajili and MyHomeDoctor partners, help clinical research through improved patient follow-up and automatic inclusion.

Sign up

Sign up
Français - English - CGU - Cookies

©2024 Kusajili France - Kusajili International - MedSynApps - MyHomeDoctor.